Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT07257822
NA

The Digital Diabetes Patient Reminder (DIPAR) Tool For Adults With Type 2 Diabetes

Sponsor: KU Leuven

View on ClinicalTrials.gov

Summary

Digital health tools may present an opportunity to address these challenges by enhancing care delivery, improving patient engagement, and facilitating better disease management for chronic diseases such as type 2 diabetes mellitus (T2DM). This primary objective of this randomized controlled trial is to evaluate whether the Diabetes Digital Patient Reminder (DIPAR), embedded in patient portal, can increase the proportion of T2DM patients who have their albuminuria measured at least once annually by either a general practitioner (GP) or a diabetes specialist, as documented in their hospital medical records (EMD), thereby reflecting active monitoring of diabetes-related parameters.

Official title: The Digital Diabetes Patient Reminder (DIPAR) Tool to Improve Clinical Outcomes and Process of Management in Adults With Type 2 Diabetes: A Proof-of-Concept Randomized Controlled Trial

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

200

Start Date

2025-10-06

Completion Date

2027-06

Last Updated

2026-02-19

Healthy Volunteers

No

Interventions

DEVICE

Digital Diabetes Patient Reminder Tool

\- Reminder function: participants will receive reminders that align with the minimal follow-up requirements in Belgium, when the HbA1c and albuminuria measurements are overdue o Notification schedule: HbA1c: First reminder after 7 months without a measurement; second reminder 4 weeks later if still overdue. Albuminuria: First reminder after 13 months without a measurement; second reminder 4 weeks later if still overdue. \- Consultation dashboard: this feature will allow the display selected diabetes clinical parameters in a visual and colorful display. The selected parameters are: HbA1c (%), LDL-C (mg/dl), systolic and diastolic blood pressure (mmHg), albuminuria (mg/gACR), eGFR (ml/min/1.73m2) and BMI (weight/lenght2). Furthermore, participants will be provided with a questionnaire that targets selfcare behaviors and are required to complete this before consultations with their diabetes-specialist or general practitioner.

OTHER

Standard of Care treatment and follow-up

This allows for the control to group to receive only their routine consultation and follow-up care as provided by their diabetes specialist.

Locations (2)

Regional Hospital of Leuven

Leuven, Flemish Brabant, Belgium

University Hospital of UZ Leuven

Leuven, Flemish Brabant, Belgium